CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2025

Jun 10, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2025-06-06

Reporting Person: MCENANY PATRICK J (Director, Chairman of Board of Directors)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-06-06	Common Stock, par value $0.001 per share	S	28252	$25.945	Disposed	4453450	Direct
2025-06-09	Common Stock, par value $0.001 per share	S	171748	$26.110	Disposed	4281702	Direct

Footnotes

F1: Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in a range from $25.906 to $25.95 per share.

F3: Represents a weighted average price for the shares sold. Shares were sold in a range from $25.765 to $26.46 per share.